Appointment of consulting firm Farthouat Finance as independent expert in connection with New Gen Holding’s proposed takeover bid followed, if necessary, by a squeeze-out, for the shares of Generix Group (GENX – FR0010501692)
On April 22, 2022, it was announced that the top management of Generix Group and Pléiade Investissement and its top managers had entered into exclusive negotiations with the Montefiore Investment fund with the objective to conclude an investment protocol providing for the creation of an ad hoc company (“New Gen Holding”) and the subsequent filing of a takeover bid followed, if necessary, by a squeeze-out, for the shares of Generix Group, for a price of 9.50 euros per share, including an additional price of 0.50 euro per share, in the event of a squeeze-out (the “Offer“).
In this context, the Supervisory Board of Generix Group has decided to appoint, unanimously and on the recommendation of the ad hoc committee made up of four members of the Supervisory Board (three of whom are independent), the firm Farthouat Finance, represented by Mrs. Marie-Ange Farthouat, as independent expert who will be in charge, in accordance with the provisions of articles 261-1 I, 1°, 2° and 4° and II of the general regulations of the French Financial Markets Authority (Autorité des marchés financiers), of delivering a report on the financial conditions of the proposed Offer.
Negotiations between the parties are proceeding as expected. The parties will keep the market informed of their progress and the next steps in the project.